.Intense Biotech Partner Editor Gabrielle Masson provided the 2024 training class of Intense 15 winn...
.Novo Nordisk has axed its once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) progressio...
.Merck & Co. has actually swiftly made back several of the prices of its own Harpoon Therapies pu...
.After BioMarin administered a spring well-maintained of its pipeline in April, the firm has actuall...
.Major Pharmas continue to be caught to the idea of molecular glue degraders. The latest provider to...
.A brand-new global life scientific research credit history agency, referred to Symbiotic Funds, has...
.Bristol Myers Squibb is axing another huge wager from the Caforio period, ending an offer for Agenu...
.After looking at stage 1 information, Nuvation Bio has actually determined to halt work on its sing...
.Zevra Therapies' uncommon illness drug seems to be on the course to approval this loss after obtain...
.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene therapy failure has actually gone a $230 t...